We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$65.1B
AUM Growth
+$4.63B
Cap. Flow
+$746M
Cap. Flow %
1.15%
Top 10 Hldgs %
9.56%
Holding
3,794
New
469
Increased
1,367
Reduced
1,237
Closed
370

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$354M
2
WFC icon
Wells Fargo
WFC
+$274M
3
IBM icon
IBM
IBM
+$266M
4
QCOM icon
Qualcomm
QCOM
+$257M
5
MDLZ icon
Mondelez International
MDLZ
+$224M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$356M
2
PYPL icon
PayPal
PYPL
+$290M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$261M
4
NVDA icon
NVIDIA
NVDA
+$248M
5
AABA
Altaba Inc
AABA
+$245M

Sector Composition

Rank Sector Weight
1 Technology 14.31%
2 Healthcare 10.66%
3 Consumer Discretionary 10.29%
4 Communication Services 8.78%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STLRW
3351
DELISTED
Stellar Acquisition III Inc. Warrants
STLRW
$76K ﹤0.01%
205,000
– –
GFI icon
3352
Gold Fields
GFI
$42.8B
$75K ﹤0.01%
17,384
-16,900
-49% -$69.3K
MACQW
3353
DELISTED
M I Acquisitions, Inc. Warrant
MACQW
$72K ﹤0.01%
205,000
– –
FCEL icon
3354
FuelCell Energy
FCEL
$1.56B
$69K ﹤0.01%
110
-22
-17% -$11.9K
ICL icon
3355
ICL Group
ICL
$7.49B
$69K ﹤0.01%
15,561
-4,100
-21% -$18.7K
SRRA
3356
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$66K ﹤0.01%
1,058
-215
-17% -$12.6K
CTLP
3357
DELISTED
Cantaloupe
CTLP
$64K ﹤0.01%
10,278
-6,561
-39% -$35.3K
TTNP
3358
DELISTED
Titan Pharmaceuticals
TTNP
$63K ﹤0.01%
10
-2
-17% -$12.4K
HSTO
3359
DELISTED
Histogen Inc. Common Stock
HSTO
$62K ﹤0.01%
+56
New +$63.7K
WIN
3360
CALL
DELISTED
Windstream Holdings Inc
WIN
$62K ﹤0.01%
7,040
– –
ANDAW
3361
DELISTED
Andina Acquisition Corp. II Warrant
ANDAW
$61K ﹤0.01%
170,000
-24,900
-13% -$7.71K
MVIS icon
3362
Microvision
MVIS
$50.8M
$59K ﹤0.01%
+1,410
New +$51K
CASC
3363
DELISTED
Cascadian Therapeutics, Inc.
CASC
$59K ﹤0.01%
14,446
-2,516
-15% -$9.63K
NVAX icon
3364
CALL
Novavax
NVAX
$1.47B
$57K ﹤0.01%
2,500
– –
SGY.WS
3365
DELISTED
Stone Energy Corporation Warrants to purchase common stock (expiring February 28, 2021)
SGY.WS
$57K ﹤0.01%
12,800
– –
SID icon
3366
Companhia Siderúrgica Nacional
SID
$1.3B
$54K ﹤0.01%
18,119
-337
-2% -$904
GLBL
3367
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$54K ﹤0.01%
11,275
– –
STNG icon
3368
Scorpio Tankers
STNG
$3.93B
$53K ﹤0.01%
+1,551
New +$56.3K
COOP
3369
DELISTED
Mr. Cooper
COOP
$52K ﹤0.01%
4,582
+577
+14% +$8.1K
ARLZ
3370
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$52K ﹤0.01%
22,512
+6,160
+38% +$8.24K
NDLS icon
3371
Noodles & Co
NDLS
$89.7M
$51K ﹤0.01%
1,441
-388
-21% -$12.8K
MMDMW
3372
DELISTED
Modern Media Acquisition Corp. Warrant
MMDMW
$48K ﹤0.01%
89,000
-1,000
-1% -$565
MMDMR
3373
DELISTED
Modern Media Acquisition Corp. Right
MMDMR
$48K ﹤0.01%
115,300
– –
CGEN icon
3374
Compugen
CGEN
$248M
$47K ﹤0.01%
12,294
-1,789
-13% -$6.21K
CXRX
3375
DELISTED
Concordia International Corp. Common Stock
CXRX
$40K ﹤0.01%
+34,000
New +$46.4K
133 134
135
136 137

Similar funds

Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

David Shaw's Q3 2017 Portfolio in Review

As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
  • David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
  • David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
  • David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
  • David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
  • David Shaw opened 469 new positions and closed 370 in Q3 2017.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.